Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunological Aspects of Approved MS Therapeutics
Paulus Rommer, Ron Milo, May Han, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
Maria Pia Sormani, Nicola De Rossi, Irene Schiavetti, et al.
Annals of Neurology (2021) Vol. 89, Iss. 4, pp. 780-789
Open Access | Times Cited: 440
T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis
Martina Kunkl, Simone Frascolla, Carola Amormino, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 482-482
Open Access | Times Cited: 188
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis
Heather Yong, V. Wee Yong
Nature Reviews Neurology (2021) Vol. 18, Iss. 1, pp. 40-55
Closed Access | Times Cited: 117
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Anthony T. Reder, Diego Centonze, Maria L. Naylor, et al.
CNS Drugs (2021) Vol. 35, Iss. 3, pp. 317-330
Open Access | Times Cited: 115
Microglia in multiple sclerosis: Protectors turn destroyers
V. Wee Yong
Neuron (2022) Vol. 110, Iss. 21, pp. 3534-3548
Open Access | Times Cited: 90
Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine–induced antibody and T cell immunity and function
Joseph J. Sabatino, Kristen Mittl, William Rowles, et al.
JCI Insight (2022) Vol. 7, Iss. 4
Open Access | Times Cited: 78
Regulatory Cells in Multiple Sclerosis: From Blood to Brain
Leticia Calahorra, Celia Camacho-Toledano, Mari Paz Serrano‐Regal, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 335-335
Open Access | Times Cited: 39
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories
Catharina C. Groß, Andreas Schulte‐Mecklenbeck, Olga V. Steinberg, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 740
Closed Access | Times Cited: 15
Building digital patient pathways for the management and treatment of multiple sclerosis
Judith Wenk, Isabel Voigt, Hernán Inojosa, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption
B. Singer, Jenny Feng, Horacio Chiong-Rivero
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3116-3130
Open Access | Times Cited: 8
Microglial Phagocytosis of Neurons: Diminishing Neuronal Loss in Traumatic, Infectious, Inflammatory, and Autoimmune CNS Disorders
Samuel F. Yanuck
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 66
Siponimod (BAF312) Activates Nrf2 While Hampering NFκB in Human Astrocytes, and Protects From Astrocyte-Induced Neurodegeneration
Emanuela Colombo, Claudia Bassani, Anthea De Angelis, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 58
Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications
Tyrell J. Simkins, Greg J. Duncan, Dennis Bourdette
Current Neurology and Neuroscience Reports (2021) Vol. 21, Iss. 6
Closed Access | Times Cited: 53
Intranasal delivery of interferon-β-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: A promising simple, effective, non-invasive, and low-cost therapy
Luis F. González, Eric Acuña, Gabriel Arellano, et al.
Journal of Controlled Release (2020) Vol. 331, pp. 443-459
Closed Access | Times Cited: 52
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
Diego Centonze, Maria A. Rocca, Claudio Gasperini, et al.
Journal of Neurology (2021) Vol. 268, Iss. 11, pp. 3961-3968
Open Access | Times Cited: 52
Targeting B Cells to Modify MS, NMOSD, and MOGAD
Jonas Graf, Jan Mareš, Michael Barnett, et al.
Neurology Neuroimmunology & Neuroinflammation (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 49
Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)
Stanley Cohan, Barry Hendin, Anthony T. Reder, et al.
CNS Drugs (2021) Vol. 35, Iss. 7, pp. 743-767
Open Access | Times Cited: 49
Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation
Arielle Kasindi, Dieu‐Trang Fuchs, Yosef Koronyo, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1578-1578
Open Access | Times Cited: 31
Pathways to healing: Plants with therapeutic potential for neurodegenerative diseases
Sheena E.B. Tyler, Luke D.K. Tyler
IBRO Neuroscience Reports (2023) Vol. 14, pp. 210-234
Open Access | Times Cited: 16
Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of Nutraceutics
Anna Signorile, Anna Ferretta, Maddalena Ruggieri, et al.
Antioxidants (2020) Vol. 10, Iss. 1, pp. 21-21
Open Access | Times Cited: 40
Increased Levels of IL-16 in the Central Nervous System during Neuroinflammation Are Associated with Infiltrating Immune Cells and Resident Glial Cells
Shehla Unaiza Hridi, Mark Barbour, C. W. M. Wilson, et al.
Biology (2021) Vol. 10, Iss. 6, pp. 472-472
Open Access | Times Cited: 36
Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis
Corey Smith, Rajiv Khanna
Clinical & Translational Immunology (2023) Vol. 12, Iss. 3
Open Access | Times Cited: 15
RNF213 promotes Treg cell differentiation by facilitating K63-linked ubiquitination and nuclear translocation of FOXO1
Xiaofan Yang, Xiaotong Zhu, Junli Sheng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
NS5 Conservative Site Is Required for Zika Virus to Restrict the RIG-I Signaling
Aixin Li, Wenbiao Wang, Yingchong Wang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 36
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
Finja Schweitzer, Sarah Laurent, Gereon R. Fink, et al.
Journal of Neurology (2020) Vol. 268, Iss. 7, pp. 2379-2389
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top